Fulgent Genetics(FLGT) - 2023 Q4 - Annual Results

Fourth Quarter 2023 Results: Note: EL MONTE, CA, February 28, 2024 — Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2023. 1) Core Revenue excludes revenue from COVID-19 testing products and services including COVID-19 NGS testing revenue. Outlook: Conference Call Information Cert ...